Krensavage Partners gained 6.7% in February, marking an exceptional month for the fund. The fund's benchmarks, the S&P Healthcare index and the S&P 500, were up 1.2% and 3.2%, respectively, for February. This year brought the strongest February for the fund since 2014, according to the firm's February performance summary, which was reviewed by ValueWalk.
Q4 hedge fund letters, conference, scoops etc

Krensavage returned 2.2% in January, compared to the S&P Healthcare index's 4.8% gain and the S&P 500's 8% gain. Year to date, the healthcare-focused value fund is up 0.1%, compared to the S&P Healthcare index's...



